ZNTL Zentalis Pharmaceuticals, Inc.
$3.51▼ -2.23%
Healthcare
Other
After hours
$3.52▲ +0.28%
Sep 11, 7:30 PM ET
Volume 787.7K
Avg Volume (10D) 788.6K
Key Metrics & Fundamentals
Market Cap
$332.30M
P/E Ratio
–
Div Yield
–%
52W Range
1.21 - 6.95
% vs 50 MA
-18.49%
% vs 200 MA
6.23%
RSI-14
37.1
MACD Histogram
+0.0000
Beta (1Y vs SPY)
2.01
Free Cash Flow
-$37.24M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$46.48M
COGS
–
Operating Exp
$44.39M
Operating Income
-$44.39M
EBIT
-$44.39M
Pretax Income
-$42.15M
Net Income
-$42.29M
EPS (Diluted)
-0.59
Price & Volume History
Loading chart…
Recent News
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 8:05 PM
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 1, 2026 9:15 PM
Zentalis Pharmaceuticals Insider Bought Shares Worth $15,172,500, According to a Recent SEC Filing
MT Newswires · Aug 20, 2026 7:55 AM
Zentalis Pharmaceuticals Closes Offering of Common Shares
MT Newswires · Aug 17, 2026 8:19 PM
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire · Aug 17, 2026 8:01 PM
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · Aug 14, 2026 7:51 PM
Sector Update: Healthcare
MT Newswires · Aug 14, 2026 7:22 PM
Update: Zentalis Pharmaceuticals Shares Fall After Pricing $80.5 Million Offering to Fund Clinical Pipeline
MT Newswires · Aug 14, 2026 6:10 PM
Zentalis Pharmaceuticals Prices $80.5 Million Offering to Fund Clinical Pipeline
MT Newswires · Aug 14, 2026 8:00 AM
Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering
GlobeNewswire · Aug 14, 2026 2:23 AM
Financial Overview - Income Statement
Quarterly
Dec 2024
See ZNTL's money flow as a full page
Social Sentiment
No Reddit posts found for ZNTL.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.